ANI PHARMACEUTICALS INC (ANIP) › RevenueANI PHARMACEUTICALS INC (ANIP) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $128.62M2017: $176.84M2018: $201.58M2019: $206.55M2020: $208.47M2021: $216.14M2022: $316.38M2023: $486.82M2024: $614.38M2025: $883.37M$883.37M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$883.37M+43.8%2024$614.38M+26.2%2023$486.82M+53.9%2022$316.38M+46.4%2021$216.14M+3.7%2020$208.47M+0.9%2019$206.55M+2.5%2018$201.58M+14.0%2017$176.84M+37.5%2016$128.62M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share